Studies on Patents and the Associated Anti-Cancer Drug Development in China

doi 10.2174/9781681083339116050007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BENTHAM SCIENCE PUBLISHERS

Related search

Technology Development Through Pooling ARV Drug Patents: A Vision From China

Open AIDS Journal
EnvironmentalPublic HealthInfectious DiseasesVirologyOccupational Health
2010English

Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII

2016English

Patients Not Patents: Drug Research and Development as a Public Enterprise

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2018English

Drug Development for Cryptococcosis Treatment: What Can Patents Tell Us?

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2019English

Studies on the Phytoplankton Development Trend in Lake Fuxian, China

Hupo Kexue/Journal of Lake Sciences
Planetary SciencesAquatic ScienceEarthWater ScienceTechnologyPollution
2007English

Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development – A Systematic Review

PLoS ONE
Multidisciplinary
2015English

Diagnostics in Cancer Drug Development

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2004English

Nonsteroidal Anti-Inflammatory Drug Use Is Associated With Cancer Risk Reduction in Chronic Dialysis Patients

Kidney International
Nephrology
2013English

Regulatory Considerations on Endpoints in Ovarian Cancer Drug Development

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy